您使用提示模式 关闭

FXH - First Trust Health Care AlphaDEX Fund (USD) (US33734X1431)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US33734X1431
FXH ISIN
交易所交易基金 (ETF)
基金类型
First Trust
提供商
122,57 USD
每股资产净值 | 2026-07-15
2007-05-08
成立日期
4 每年的次数
股息的支付
CEOJLS
CFI
FXH
代码
Formed
Status
Equity
投资项目
Healthcare
部门
USA
地区分布
StrataQuant(R) Health Care Index.
基准
0.62 %
总成本比率
1.005,07 百万 USD
基金资产总量 | 2026-07-15
1.005,07 百万 USD
股票类资产 | 2026-07-15
否
UCITS

收益率 在 2026-07-15, NYSE Arca

  • YTD
    -1,11 %
  • 1M
    -1,3 %
  • 3M
    -1,89 %
  • 6M
    1,42 %
  • 1Y
    10,58 %
  • 3Y
    8,75 %
  • 5Y
    2,21 %
  • 10Y
    101,62 %
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (FXH)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

FXH profile

The First Trust Health Care AlphaDEX Fund (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 08.05.2007 with unique ISIN - US33734X1431. Main exchange is NYSE Arca and ticker symbol is FXH. The total expense ratio is 0.62%. The First Trust Health Care AlphaDEX Fund (USD) pays dividends 4 time(s) per year.

结构 FXH 在 2026-07-15

下载结构至 Excel 文档
证券 值
Guardant Health, Inc. 2,55%
The Cigna Group 2,53%
Regeneron Pharmaceuticals, Inc. 2,5%
Zimmer Biomet Holdings, Inc. 2,46%
DaVita Inc. 2,44%
Centene Corporation 2,43%
Pfizer Inc. 2,42%
Natera, Inc. 2,4%
Solventum Corporation 2,38%
Boston Scientific Corporation 2,37%
Medline Inc. (Class A) 2,35%
Universal Health Services, Inc. (Class B) 2,34%
Globus Medical, Inc. (Class A) 2,33%
Axsome Therapeutics, Inc. 2,28%
Encompass Health Corporation 1,9%
QIAGEN N.V. 1,85%
Zoetis Inc. 1,82%
Corcept Therapeutics Inc. 1,8%
Tenet Healthcare Corporation 1,8%
Medtronic Plc 1,8%
Neurocrine Biosciences, Inc. 1,79%
Incyte Corporation 1,78%
ResMed Inc. 1,78%
Elevance Health Inc. 1,77%
Ascendis Pharma A/S 1,76%
United Therapeutics Corporation 1,72%
Halozyme Therapeutics, Inc. 1,7%
Eli Lilly and Company 1,69%
Arrowhead Pharmaceuticals, Inc. 1,54%
Doximity, Inc. (Class A) 1,51%
Viatris Inc. 1,48%
Gilead Sciences, Inc. 1,47%
Becton, Dickinson and Company 1,44%
Exelixis, Inc. 1,44%
Bristol-Myers Squibb Company 1,43%
Steris Plc 1,41%
Medpace Holdings, Inc. 1,41%
GE HealthCare Technologies Inc. 1,39%
Revolution Medicines, Inc. 1,39%
Labcorp Holdings Inc. 1,37%
Quest Diagnostics Incorporated 1,34%
Biogen Inc. 1,28%
Ionis Pharmaceuticals, Inc. 0,97%
BridgeBio Pharma, Inc. 0,97%
Veeva Systems Inc. (Class A) 0,96%
Align Technology, Inc. 0,94%
IQVIA Holdings Inc. 0,94%
Thermo Fisher Scientific Inc. 0,94%
Chemed Corporation 0,93%
Henry Schein, Inc. 0,91%
Madrigal Pharmaceuticals, Inc. 0,9%
Agilent Technologies, Inc. 0,89%
Tempus AI, Inc. (Class A) 0,87%
Organon & Co. 0,87%
Abbott Laboratories 0,86%
AbbVie Inc. 0,85%
HCA Healthcare, Inc. 0,85%
Vertex Pharmaceuticals Incorporated 0,84%
DexCom, Inc. 0,47%
Illumina, Inc. 0,47%
IDEXX Laboratories, Inc. 0,46%
The Ensign Group, Inc. 0,46%
Danaher Corporation 0,46%
BioMarin Pharmaceutical Inc. 0,45%
Bio-Rad Laboratories, Inc. (Class A) 0,44%
Envista Holdings Corporation 0,44%
Revvity, Inc. 0,44%
Stryker Corporation 0,44%
West Pharmaceutical Services, Inc. 0,44%
The Cooper Companies, Inc. 0,43%
Johnson & Johnson 0,43%
Amgen Inc. 0,43%
Merck & Co., Inc. 0,42%
US Dollar 0,21%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权